Home › NDC Lookup › RxCUI directory › RxCUI 858806

Enalapril maleate 2.5 MG Oral Tablet [Vasotec] — RxCUI 858806

RxNorm drug concept · Semantic branded drug
RxCUI 858806 Semantic branded drug · SBD ● Current RxNorm concept 4 FDA products 10 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI858806
Official nameEnalapril maleate 2.5 MG Oral Tablet [Vasotec]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asVasotec 2.5 MG Oral Tablet
FDA products mapped4
Package NDCs mapped10
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Enalapril: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats high blood pressure and heart failure. It is also used when the heart’s pumping function is weak but you don’t have symptoms yet, to slow progression to heart failure. Lo...
  • Take it by mouth, as a tablet or oral solution, once or twice a day as prescribed. Food does not affect tablet absorption. Don’t change your dose on your own, and ask me if you mis...
  • Most people tolerate it well. You may feel tired or dizzy, especially when starting. Stand up slowly, and tell your doctor if dizziness is bothersome.
  • Get emergency help for swelling of the face, lips, tongue or throat, or trouble breathing. Call your doctor for severe stomach pain, yellowing of your skin or eyes, or fainting.
📖 Read our full Enalapril guide →

🕸️ Concept Web — How Enalapril maleate 2.5 MG Oral Tablet [Vasotec] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Enalapril maleate 2.5 MG Oral Tablet [Vasotec] RxCUI 858806

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Enalapril 3827
    • Enalapril maleate 203123
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vasotec 224921
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Enalapril Oral Tablet 372007
    • Enalapril maleate Oral Tablet 2648769
    • Enalapril Oral Product 1162652
    • Enalapril Pill 1162653
    • Enalapril maleate Oral Product 2661893
    • Enalapril maleate Pill 2659867
    • Enalapril Oral Tablet [Vasotec] 369505
    • Enalapril maleate Oral Tablet [Vasotec] 2655646
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Enalapril maleate 2.5 MG Oral Tablet SCD · 858804
  • Enalapril maleate 2.5 MG SCDC · 858803
  • Enalapril Oral Tablet SCDF · 372007
  • Enalapril maleate Oral Tablet SCDFP · 2648769
  • Enalapril Oral Product SCDG · 1162652
  • Enalapril Pill SCDG · 1162653
  • Enalapril maleate Oral Product SCDGP · 2661893
  • Enalapril maleate Pill SCDGP · 2659867

Brand-Name Concepts

  • Enalapril maleate 2.5 MG [Vasotec] SBDC · 858805
  • Enalapril Oral Tablet [Vasotec] SBDF · 369505
  • Enalapril maleate Oral Tablet [Vasotec] SBDFP · 2655646
  • Vasotec Oral Product SBDG · 1187734
  • Vasotec Pill SBDG · 1187735
  • Vasotec BN · 224921

📦 FDA Products & Package NDCs

4 products · 10 package NDCs
10 package NDCs map to RxCUI 858806 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00187-0140-30 30 TABLET in 1 BOTTLE (0187-0140-30) Vasotec Bausch Health US LLC 1988-07-26
00187-0140-90 90 TABLET in 1 BOTTLE (0187-0140-90) Vasotec Bausch Health US LLC 1988-07-26
00187-0141-30 30 TABLET in 1 BOTTLE (0187-0141-30) Vasotec Bausch Health US LLC 1985-12-24
00187-0141-90 90 TABLET in 1 BOTTLE (0187-0141-90) Vasotec Bausch Health US LLC 1985-12-24
00187-0142-10 1000 TABLET in 1 BOTTLE (0187-0142-10) Vasotec Bausch Health US LLC 1985-12-24
00187-0142-30 30 TABLET in 1 BOTTLE (0187-0142-30) Vasotec Bausch Health US LLC 1985-12-24
00187-0142-90 90 TABLET in 1 BOTTLE (0187-0142-90) Vasotec Bausch Health US LLC 1985-12-24
00187-0143-10 1000 TABLET in 1 BOTTLE (0187-0143-10) Vasotec Bausch Health US LLC 1985-12-24
00187-0143-30 30 TABLET in 1 BOTTLE (0187-0143-30) Vasotec Bausch Health US LLC 1985-12-24
00187-0143-90 90 TABLET in 1 BOTTLE (0187-0143-90) Vasotec Bausch Health US LLC 1985-12-24
Observed labelers: Bausch Health US LLC (10) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.